The U.S. Justice Department (DOJ) is investigating whether Sanofi and Bristol-Myers Squibb failed to adequately disclose information that was known about variations in the effectiveness of Plavix, their blockbuster blood…
The U.S. Judicial Panel on Multidistrict Litigation (JPML) has decided to consolidate all Plavix lawsuits filed in the federal court system before one judge for coordinated handling during pretrial proceedings,…
A panel of federal judges will hear oral arguments next month over a motion to consolidate all federal Plavix lawsuits, reconsidering whether the cases should be centralized before one judge…
In response to a second request filed by Bristol-Myers Squibb and Sanofi-Aventis to centralize all Plavix lawsuits pending in the federal court system, various plaintiffs have filed responses opposing the…
Bristol-Myers Squibb and Sanofi-Aventis have filed a second request to consolidate and centralize all Plavix lawsuits filed in U.S. District Courts throughout the country, asking a panel of federal judges…
A Tennessee woman has filed a product liability lawsuit in New York state court against Bristol-Myers Squibb and Sanofi-Aventis, alleging that she sufferd gastrointestinal bleeding from side effects of Plavix.
A new study has identified possible ways to reverse the effects of a proposed blood thinner that belongs to the same class of anticoagulants as Pradaxa, which has been associated…
Bristol-Myers Squibb and Sanofi Aventis face more than 80 new lawsuits filed in recent weeks over gastrointestinal bleeding from Plavix, a blockbuster blood thinner that has been used by millions…
A wrongful death lawsuit has been filed against Boehringer Ingelheim on behalf of a Tennessee woman who bled to death, allegedly due to side effects of Pradaxa.
Boehringer Ingleheim’s relatively new anticoagulant Pradaxa has hit blockbuster status, even amid hundreds of deaths and other serious injuries caused by bleeding problems experienced by users of the medication.
